
Syngen Laboratories Private Limited
About Syngen Laboratories Private Limited
Data last updated:
Syngen Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 14 January 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PTC042436. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Giridhar Thota and Shobha Thota.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Krishe Sapphire 6th Floor 6B Survey No.88 Madhapur Village Serilingampalli Mandal, Hyderabad, Telangana, India – 500081.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.63 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹10.74 Lakh (net margin 78.8%) and EBITDA of ₹13.63 Lakh (EBITDA margin 100%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Syngen Laboratories has one previous CIN (Corporate Identification Number): U24239AP2004PTC042436. The current CIN is U24239TG2004PTC042436, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PTC042436 | Current |
| U24239AP2004PTC042436 | Previous |
Contact details
Syngen Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKrishe Sapphire 6th Floor 6B Survey No.88 Madhapur Village Serilingampalli Mandal, Hyderabad, Telangana, India – 500081
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Syngen Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Syngen Laboratories Private Limited
FY 2025 filings availableSyngen Laboratories Private Limited reported revenue of ₹13.63 Lakh (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 4% growth in the latest year. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.63 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.74 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 100% | ||||
| Net Profit Margin | 78.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Syngen Laboratories Private Limited, buy the company report.
Board of directors of Syngen Laboratories Private Limited
Syngen Laboratories has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Giridhar Thota Also directs: Spica Laboratories Private Limited, Sahasra Laboratories Private Limited, Medha Dyechem Pvt Ltd and 2 more | Director | 14 Jan 2004 | 22 Years 9 Months | Current |
| Shobha Thota Also directs: Spica Laboratories Private Limited, Sahasra Laboratories Private Limited, Medha Dyechem Pvt Ltd and 2 more | Director | 01 Apr 2007 | 19 Years 7 Months | Current |
Peer comparison
Syngen Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nutriasia Life Sciences Private Limited | ₹13.85 Lakh (FY 2025) | -4.0% | Delhi, India | |||
| Zeycnovo Life Sciences Private Limited | ₹13.76 Lakh (FY 2025) | -97.0% | Indore, Madhya Pradesh, India | |||
| Maatrikaa Life Sciences Private Limited | ₹13.72 Lakh (FY 2023) | Vadodara, Gujarat, India | ||||
| Inexios Pharmaceuticals Private Limited | ₹13.72 Lakh (FY 2025) | 23.0% | Bangalore, Karnataka, India | |||
| Pilco Pharma Private Limited | ₹13.66 Lakh (FY 2020) | Kanpur, Uttar Pradesh, India | ||||
| Syngen Laboratories Private Limitedthis company | ₹13.63 Lakh (FY 2025) | ₹10.74 Lakh | 78.8% | 4.0% | Hyderabad, Telangana, India | |
| Sangie Pharmaceuticals Private Limited | ₹13.57 Lakh (FY 2025) | -80.0% | Thane, Maharashtra, India | |||
| Pharma Base India Private Limited | ₹13.51 Lakh (FY 2025) | -99.0% | Mumbai, Maharashtra, India | |||
| Plazma Laboratories Pvt Ltd | ₹13.49 Lakh (FY 2025) | Indore, Madhya Pradesh, India | ||||
| Amishi Naturals Private Limited | ₹13.47 Lakh (FY 2018) | Karnal, Haryana, India | ||||
| Bayomac India Private Limited | ₹13.43 Lakh (FY 2023) | 38.0% | New Delhi, Delhi, India |
To see the full peer comparison of Syngen Laboratories Private Limited, buy the company report.
Auditor
Syngen Laboratories Private Limited is audited by V.S GANESH for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.S GANESH | FY 2017 | 026138 |
Shareholding
The shareholding of Syngen Laboratories Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Syngen Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Syngen Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Syngen Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Syngen Laboratories has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Syngen Laboratories Private Limited, buy the company report.
Recent activity
Syngen Laboratories Private Limited has 2 board changes on record since 2004: 2 appointments. The latest: Shobha Thota was appointed as Director on 01 Apr 2007.
Frequently asked questions
Syngen Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in chemical products, within the chemicals industry. It was incorporated on 14 January 2004 (22+ years old) and is registered under CIN U24239TG2004PTC042436.
Syngen Laboratories has 2 current directors:
- Giridhar Thota - Director
- Shobha Thota - Director
The latest financial statements of Syngen Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Syngen Laboratories has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Syngen Laboratories is U24239TG2004PTC042436. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Syngen Laboratories was incorporated on 14 January 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Syngen Laboratories by revenue are Nutriasia Life Sciences Private Limited, Zeycnovo Life Sciences Private Limited, Maatrikaa Life Sciences Private Limited, Inexios Pharmaceuticals Private Limited, Pilco Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Shobha Thota was appointed as Director on 01 Apr 2007. Giridhar Thota was appointed as Director on 14 Jan 2004.
The registered office of Syngen Laboratories is at Krishe Sapphire 6th Floor 6B Survey No.88 Madhapur Village Serilingampalli Mandal, Hyderabad, Telangana, India – 500081.
Syngen Laboratories operates in the chemicals industry, in the chemical products segment.
The compliance status of Syngen Laboratories is compliant as of 07 August 2026. The company is actively filing with the Registrar of Companies.

